Patent · US Active

Method for determining sepsis using pro-ADM

US7972799B2 · kind B2 · utility

12Cited by
3References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 18, 2009
Grant dateJul 5, 2011
Priority date
Expiry dateFeb 18, 2029

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/585
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Uses of recombinant procalcitonin 3-116 in the diagnosis and therapy of septic diseases and the measurement of prohormones other than procalcitonin, and of dipeptidyl peptidase IV, as biomarkers in the diagnosis of sepsis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.